Less than one-quarter (23%) of children with HIV/AIDS who need treatment are getting it, according to a report released by the World Health Organization (WHO) on the occasion of World AIDS Day (1 December 2011). Although ...
Dec 1, 2011
0
0
Just over 40 years ago, the first case of acquired immunodeficiency syndrome—more commonly known as AIDS—was reported, setting into motion a worldwide panic about the unknown, devastating disease. At the time, AIDS was ...
Dec 1, 2023
0
0
(AP) -- A pill that has long been used to treat HIV has moved one step closer to becoming the first drug approved to prevent healthy people from becoming infected with the virus that causes AIDS.
May 8, 2012
0
0
As the globe marks another World AIDS Day on Dec. 1, it's crucial to both acknowledge the significant strides made in the global battle against HIV and recognize the persistent challenges that remain. While the United States ...
Dec 4, 2023
0
0
Ahead of World AIDS Day on Friday, here is a snapshot in numbers, based on UN data, of the deadly disease which was identified in the early 1980s.
Nov 30, 2017
0
2
For nearly three decades, daily antiretroviral pills have offered patients living with HIV a highly effective way to keep their infection under control.
Jul 5, 2023
0
16
(AP) -- China will have about 780,000 people infected with the AIDS virus by the end of this year, state media reported Wednesday, with most having contracted it through heterosexual sex.
Nov 30, 2011
0
0
Food insecurity increases the risk of death among injection drug users living with HIV/AIDS even when they are receiving life-prolonging antiretroviral therapy (ART), according to a new study involving Simon Fraser University.
May 31, 2013
0
0
In South Africa, people with HIV who start treatment with anti-AIDS drugs (antiretroviral therapy) have life expectancies around 80% of that of the general population provided that they start treatment before their CD4 count ...
Apr 9, 2013
0
0
A once-a-day pill to help prevent HIV infection could significantly reduce the spread of AIDS, but only makes economic sense if used in select, high-risk groups, Stanford University researchers conclude in a new study.
Apr 16, 2012
0
0
